Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-03-25

Clinical Trial Update: Diuretic Use in Hemodialysis Patients With Residual Renal Function [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating diuretic use in hemodialysis patients with residual renal function has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: End Stage Renal Disease on Dialysis | Phase 4 | Status: SUSPENDED